PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
30291293-0	2018	Ankyrin Repeat Domain 1 Overexpression is Associated with Common Resistance to Afatinib and Osimertinib in EGFR-mutant Lung Cancer.	osimertinib	92-103	ankyrin repeat domain 1	Homo sapiens	0-23	
30291293-6	2018	When ANKRD1 was silenced in the EGFR-TKIs-resistant cell lines, afatinib and osimertinib could induce apoptosis of the cell lines.	osimertinib	77-88	ankyrin repeat domain 1	Homo sapiens	5-11	
30291293-7	2018	Imatinib could inhibit ANKRD1 expression, resulting in restoration of the sensitivity to afatinib and osimertinib of EGFR-TKI-resistant cells.	osimertinib	102-113	ankyrin repeat domain 1	Homo sapiens	23-29